Buffalo Grove, IL, United States of America

Russell C Klix

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Russell C Klix: Innovator in Pharmaceutical Prodrugs

Introduction

Russell C Klix is a notable inventor based in Buffalo Grove, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs for treating Parkinson's disease. With a total of 4 patents to his name, Klix has established himself as a key figure in medical innovation.

Latest Patents

One of Klix's latest patents focuses on carbidopa and L-dopa prodrugs and methods of use. This patent relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions. The innovative approach involves administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease, aiming to improve treatment outcomes.

Career Highlights

Throughout his career, Klix has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Some of Klix's notable coworkers include Benoit Cardinal-David and Vincent S Chan. Their collaboration has likely played a role in the successful development of his patents and innovations.

Conclusion

Russell C Klix is a distinguished inventor whose work in pharmaceutical prodrugs has the potential to significantly impact the treatment of Parkinson's disease. His contributions to the field are marked by a commitment to innovation and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…